Tradestie Institutional Equity Comparison Engine

DTIL vs AKTS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DTIL Overall Edge

DTIL Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Precision BioSciences, Inc. Common Stock (DTIL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DTIL trades at 11.8x Forward P/E with -80.3% operating margin (+37272.4% YoY revenue) versus AKTS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DTIL sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro) against AKTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DTIL
DTIL 11.8x vs AKTS N/M Fwd P/E
Growth & Margin Winner DTIL
Op Margin -80.3% vs N/A ยท YoY +37272.4% vs N/A
Momentum & Technical Winner DTIL
1Y +26.2% vs -26.1% ยท 52W Pos 50% vs 13%
Options & Structure Winner DTIL
CONSOLIDATION (14th %ile IV) vs UNCLASSIFIED (N/A IV)
DTIL NASDAQ
Precision BioSciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.38
-2.38% 1D
Market Cap $306.9M
1M Return +27.99%
1Y Return +26.24%
Forward P/E 11.8x
Unified AI Score
41.0 / 100 SELL
Tech 15.0 Fund 43.0 Flow 70.0 Mom 50.0
AKTS US Equity
AKTS
Institutional Equity
$16.55
-0.42% 1D
Market Cap N/A
1M Return +9.89%
1Y Return -26.12%
Forward P/E N/M
Unified AI Score
30.6 / 100 SELL
Tech 20.0 Fund 36.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DTIL +26.24% AKTS -26.12% Spread: +114.51 pp (DTIL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DTIL TTM Op. Margin: -80.3% AKTS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DTIL vs AKTS. Trailing 12-month operating profitability (DTIL -80.3% vs AKTS N/A) and valuation multiples (DTIL 11.8x vs AKTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DTIL (9) vs AKTS (1)
Institutional Metric DTIL AKTS Criterion Row Winner
Market Capitalization Scale $306.9M N/A Larger Scale DTIL
Trailing P/E Ratio Valuation 32.2x N/M Lower Multiple DTIL
Forward P/E Ratio Valuation 11.8x N/M Lower Multiple DTIL
Revenue Growth (YoY) Growth +37272.4% N/A Higher Growth DTIL
Operating Margin (TTM) Profitability -80.3% N/A Higher Margin DTIL
Net Profit Margin Profitability -85.6% N/A Higher Margin DTIL
Return on Equity (ROE) Capital Efficiency -115.3% N/A Higher ROE DTIL
52-Week Range Position Momentum 50% ($4โ€“$11) 13% ($14โ€“$34) Stronger Trend DTIL
Beta / 30D Volatility Risk Regime 0.33ฮฒ ยท 126% Vol 1.35ฮฒ ยท 67% Vol Lower Realized Risk AKTS
Unified Institutional Score Composite Signal 41.0 / 100 (SELL) 30.6 / 100 (SELL) Higher Composite DTIL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DTIL vs AKTS Buy Guide
DTIL CONSOLIDATION
129d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DTIL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AKTS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AKTS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DTIL nor AKTS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.